[EN] 1,3-SUBSTITUTED AZETIDINE PDE10 INHIBITORS<br/>[FR] INHIBITEURS AZÉTIDINES SUBSTITUÉS EN 1,3 DE PDE10
申请人:MERCK SHARP & DOHME
公开号:WO2013052395A1
公开(公告)日:2013-04-11
The present invention is directed to substituted azetidinecompounds which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 10 (PDE10). The present invention also relates to the use of such compounds for treating neurological and psychiatric disorders, such as schizophrenia, psychosis or Huntington's disease, and those associated with striatal hypofunction or basal ganglia dysfunction.
本发明涉及用作治疗与磷酸二酯酶10(PDE10)相关的中枢神经系统疾病的治疗药物的取代氮杂环丙烷化合物。本发明还涉及利用这类化合物治疗神经和精神障碍,如精神分裂症、精神病或亨廷顿病,以及与纹状体功能不足或基底神经节功能障碍相关的疾病。